Form 8-K - Current report:
SEC Accession No. 0000950170-24-092265
Filing Date
2024-08-07
Accepted
2024-08-07 07:02:18
Documents
59
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20240807.htm   iXBRL 8-K 42131
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 148938
3 EX-99.2 lrmr-ex99_2.htm EX-99.2 47977
4 GRAPHIC img46574298_0.jpg GRAPHIC 282533
5 GRAPHIC lrmr-ex99_2s1.jpg GRAPHIC 213987
6 GRAPHIC lrmr-ex99_2s2.jpg GRAPHIC 740141
7 GRAPHIC lrmr-ex99_2s3.jpg GRAPHIC 565697
8 GRAPHIC lrmr-ex99_2s4.jpg GRAPHIC 446014
9 GRAPHIC lrmr-ex99_2s5.jpg GRAPHIC 421334
10 GRAPHIC lrmr-ex99_2s6.jpg GRAPHIC 373089
11 GRAPHIC lrmr-ex99_2s7.jpg GRAPHIC 369165
12 GRAPHIC lrmr-ex99_2s8.jpg GRAPHIC 394298
13 GRAPHIC lrmr-ex99_2s9.jpg GRAPHIC 482447
14 GRAPHIC lrmr-ex99_2s10.jpg GRAPHIC 377873
15 GRAPHIC lrmr-ex99_2s11.jpg GRAPHIC 373279
16 GRAPHIC lrmr-ex99_2s12.jpg GRAPHIC 451680
17 GRAPHIC lrmr-ex99_2s13.jpg GRAPHIC 417872
18 GRAPHIC lrmr-ex99_2s14.jpg GRAPHIC 198920
19 GRAPHIC lrmr-ex99_2s15.jpg GRAPHIC 436653
20 GRAPHIC lrmr-ex99_2s16.jpg GRAPHIC 371286
21 GRAPHIC lrmr-ex99_2s17.jpg GRAPHIC 371505
22 GRAPHIC lrmr-ex99_2s18.jpg GRAPHIC 458746
23 GRAPHIC lrmr-ex99_2s19.jpg GRAPHIC 563839
24 GRAPHIC lrmr-ex99_2s20.jpg GRAPHIC 213956
25 GRAPHIC lrmr-ex99_2s21.jpg GRAPHIC 201536
26 GRAPHIC lrmr-ex99_2s22.jpg GRAPHIC 389813
27 GRAPHIC lrmr-ex99_2s23.jpg GRAPHIC 158589
28 GRAPHIC lrmr-ex99_2s24.jpg GRAPHIC 446144
29 GRAPHIC lrmr-ex99_2s25.jpg GRAPHIC 346027
30 GRAPHIC lrmr-ex99_2s26.jpg GRAPHIC 310144
31 GRAPHIC lrmr-ex99_2s27.jpg GRAPHIC 437659
32 GRAPHIC lrmr-ex99_2s28.jpg GRAPHIC 377666
33 GRAPHIC lrmr-ex99_2s29.jpg GRAPHIC 354144
34 GRAPHIC lrmr-ex99_2s30.jpg GRAPHIC 141893
35 GRAPHIC lrmr-ex99_2s31.jpg GRAPHIC 390402
36 GRAPHIC lrmr-ex99_2s32.jpg GRAPHIC 438228
37 GRAPHIC lrmr-ex99_2s33.jpg GRAPHIC 345501
38 GRAPHIC lrmr-ex99_2s34.jpg GRAPHIC 349920
39 GRAPHIC lrmr-ex99_2s35.jpg GRAPHIC 355224
40 GRAPHIC lrmr-ex99_2s36.jpg GRAPHIC 241856
41 GRAPHIC lrmr-ex99_2s37.jpg GRAPHIC 173211
42 GRAPHIC lrmr-ex99_2s38.jpg GRAPHIC 289829
43 GRAPHIC lrmr-ex99_2s39.jpg GRAPHIC 348091
44 GRAPHIC lrmr-ex99_2s40.jpg GRAPHIC 372373
45 GRAPHIC lrmr-ex99_2s41.jpg GRAPHIC 375162
46 GRAPHIC lrmr-ex99_2s42.jpg GRAPHIC 148468
47 GRAPHIC lrmr-ex99_2s43.jpg GRAPHIC 420325
48 GRAPHIC lrmr-ex99_2s44.jpg GRAPHIC 145206
49 GRAPHIC lrmr-ex99_2s45.jpg GRAPHIC 487214
  Complete submission text file 0000950170-24-092265.txt   23170997

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20240807.xsd EX-101.SCH 23892
61 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20240807_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 241181375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)